The Covid Inquiry told ministers the vaccine damage payment, frozen at £120,000 since 2007, must rise with inflation now. The government's answer accepts the case and commits to no figure and no date.
Estimated reading time: 7 minutes
In short. The government's response to the Covid-19 Inquiry's Module 4 report opens by saying it "broadly agrees with the chair's recommendations and sets out actions to address them" (page 5) [[2]]. Recommendation 5 told the government the Vaccine Damage Payment Scheme "must" be reformed "as soon as possible", with four named minimums including raising the £120,000 payment, unrevised since 2007, "at least in line with inflation to date" (page 21) [[2]]. The Inquiry calculated that an inflationary uplift to December 2025 would put the payment "in excess of £200,000" (page 239) [[3]]. The government's response accepts reform is needed and commits to none of the four minimums, only to "reviewing the scheme" with "further details in due course" (pages 21 to 22) [[2]]. A second recommendation asked all four UK governments to "publish a report annually" on vaccine equity progress; the response states plainly it will do so "rather than publishing a single annual report" (page 14) [[2]]. Three documented mistakes: four stars.
The UK Covid-19 Inquiry published its Module 4 report on 16 April 2026, examining the development, procurement and deployment of vaccines and therapeutics during the pandemic, alongside vaccine safety, public confidence and the Vaccine Damage Payment Scheme [[3]]. The Department of Health and Social Care's formal response, Command Paper CP 1684, was presented to Parliament by the Secretary of State for Health and Social Care and published 16 October 2026 [[1]]. It answers the Inquiry's five numbered recommendations one by one. Its opening line about them is unqualified: "the government broadly agrees with the chair's recommendations and sets out actions to address them" (page 5) [[2]]. Read past the opening line, and that is not what two of the five answers do.
The claims, tested
| The claim | What we found | Verdict |
|---|---|---|
| Recommendation 5: "The UK government must reform the Vaccine Damage Payment Scheme as soon as possible. The reform should include as a minimum: increasing the £120,000 payment, at least in line with inflation to date; subsequently applying annual increases in line with inflation; introducing multiple levels of payment, commensurate with the degree of injury suffered; and any transitional arrangements necessary" (page 21) [[2]] | The government's response: "accepts that there is a need for reform of the Vaccine Damage Payment Scheme, and is committed to reviewing the scheme to ensure it is fit for purpose." It commits to no figure, no inflation link, no tiered payments and no transitional arrangements, stating only that it "will provide further details in due course" (pages 21 to 22) [[2]]. The Inquiry's own calculation: the £120,000 cap, last revised in 2007, would be "in excess of £200,000" if it had simply tracked inflation to December 2025 (page 239) [[3]] | A recommendation that uses the word "must" and sets four specific minimums gets a response that commits to none of the four, with no date for when it will |
| Recommendation 2: all four UK governments "should publish a report annually on progress against these actions" to improve vaccine uptake and reduce inequalities (page 11) [[2]] | The response: "To avoid duplicating existing work, we will focus on aligning any reporting progress with existing assurance and publication routes rather than publishing a single annual report" (page 14) [[2]] | The one measurable, checkable accountability mechanism the Inquiry asked for is declined by name, inside a response whose opening page claims to broadly agree with the recommendations it answers |
| Recommendation 1: a "standing pharmaceutical expert advisory panel" that would "form the basis of specialist taskforces" during a pandemic "with sufficient autonomy, delegation and direct access to senior ministers, similar to that which worked well in the Covid-19 pandemic" (page 7) [[2]] | The response proposes "a modified version of the recommendation", an "industry stakeholder advisory group" with no delegated authority: "Responsibility for overseeing preparedness and setting strategic direction will remain with government" (page 8) [[2]] | The element of the recommendation that mattered most in the Inquiry's own account, delegated autonomy during a pandemic like the Vaccine Taskforce had, is the one the response explicitly keeps with government instead |
The mistakes, counted
A "must" recommendation with four named minimums gets zero of the four (1). The Inquiry did not leave the Vaccine Damage Payment Scheme recommendation open-ended. It said the scheme "must" be reformed, used the phrase "as soon as possible", and listed four specific minimums: an inflation-linked rise in the £120,000 cap, subsequent annual inflation increases, a tiered payment structure by severity of injury, and transitional fairness arrangements [[2]]. The Inquiry did the arithmetic too: the £120,000 figure, set by statutory order in 2007 and never revised since, would exceed £200,000 today if it had simply kept pace with inflation [[3]]. The government's response agrees reform is needed, thanks "everyone who came forward to be vaccinated", and then commits to a scheme review with "further details in due course" [[2]]. No figure. No date. None of the four minimums named, let alone met.
The one quantifiable accountability ask in recommendation 2 is turned down, not qualified (2). The Inquiry's recommendation on vaccine equity had several strands, and the government's response engages seriously with most of them: community networks, an NHS England outreach programme, a Four Nations Forum equity subgroup established in 2026. But one strand was specific and measurable, an annual public report from all four UK governments on progress against agreed actions [[2]]. The response does not fold that into something broader or promise to consider it. It states the choice directly: existing reporting routes "rather than publishing a single annual report" [[2]]. That is a legitimate position to take. It is not "broadly agreeing" with the recommendation it answers, and the response's own opening page does not flag the distinction.
The one structural change the recommendation asked for is the one withheld (3). Recommendation 1 did not just ask for an advisory panel to exist. It specified a panel that could, during a pandemic, form "specialist taskforces" with "sufficient autonomy, delegation and direct access to senior ministers, similar to that which worked well in the Covid-19 pandemic", an explicit reference to how the original Vaccine Taskforce operated [[2]]. The government's response agrees expert advice matters, cites the Vaccine Taskforce's own success as a reason to act, and then proposes a body built the opposite way: an advisory group whose role is advisory, with "responsibility for overseeing preparedness and setting strategic direction" staying with government [[2]]. The recommendation's central structural ask, delegated authority, is the one part of it the response does not adopt.
Credit where due
The response is not evasive about what it is doing. On both recommendation 2 and recommendation 5 it states its position in plain terms rather than burying a decline in hedge language; a reader who gets past the opening page can see exactly where the response falls short of the ask. It also commits to genuinely concrete, checkable work elsewhere: delegating vaccination service commissioning to integrated care boards with performance tracked through the NHS Outcomes Framework, a single vaccination record planned for the NHS App, and a Pandemic Preparedness Strategy due a formal review in 2028 that will fold in later Inquiry findings [[2]]. On recommendation 4, covering regulators' access to linked health records, the Inquiry's own ask was less prescriptive than recommendation 5's four minimums, and the response's acknowledgement that delivery "is likely to require significant investment over time" is a fair description of a UK-wide data-linkage programme, not evasion of a number the Inquiry itself did not set [[2]]. And on the substance of the pandemic response, the government's account checks out: Module 4 did find the UK's vaccine rollout saved lives and eased pressure on the NHS, a conclusion this piece does not dispute [[3]].
Verdict
Four stars, from three documented mistakes. The government's response to a Covid Inquiry recommendation that says a compensation scheme "must" change, with four stated minimums and the Inquiry's own figure for how far behind inflation it has fallen, commits to none of the four and sets no date. A second recommendation's one measurable accountability mechanism is declined by name inside a response that opens by claiming broad agreement. And the one structural change a third recommendation specifically asked for, delegated authority for an expert panel during a future health emergency, is the one element the response's substitute body does not carry.
The star score counts three documented mistakes. First, the response to recommendation 5 commits to no figure, no inflation link, no tiered payments and no transitional arrangements, despite the Inquiry's recommendation using the word "must" and naming all four as minimums. Second, the response to recommendation 2 declines the Inquiry's request for an annual public report on vaccine equity progress, without the opening page's "broadly agrees" framing flagging the decline. Third, the response to recommendation 1 proposes an advisory body with no delegated authority, where the Inquiry's recommendation specifically asked for delegated autonomy modelled on the pandemic-era Vaccine Taskforce. Three falls in the 1 to 3 band: four stars; the bands are on the ratings page. This piece makes no finding about the conduct of any named individual; no minister or official is quoted or named in connection with any of the three findings. Checked directly against the government's response document, the Inquiry's Module 4 full report and the government's own publication page, all fetched and read in full 17 October 2026.
Sources
- UK government response to the Covid-19 Inquiry Module 4 report (GOV.UK), Department of Health and Social Care, published 16 October 2026
- UK government response to the Covid-19 Inquiry Module 4 report, CP 1684 (PDF), Department of Health and Social Care, published 16 October 2026
- Module 4 Report: Vaccines and Therapeutics, UK Covid-19 Inquiry, published 16 April 2026